• Home
  • Getting Started
    • ChartMill OverviewGrowth TradersTechnical Swing Traders Long Term Investors
  • Tools
    • Stock ScreenerStock ChartsFull Screen Stock ChartsMarket MonitorSectorsEarningsAnalyzerInsider TradingUp- and Downgrades
  • Stock Market
    • Top Gainers and LosersNew 52 Week High and LowGap Up and Gap DownMost ActivePremarket MoversAfter-Hours MoversEarnings CalendarUSA Market OverviewCanada Market OverviewEurope Market Overview
  • Trading Ideas
  • News
  • Blog
  • Documentation
    • Documentation CenterVideosIndicatorsPropertiesScreener Market data
  • Popular Articles
    • Bull FlagsRelative StrengthPocket PivotsSupport and ResistanceRSI IndicatorMACD IndicatorPiotroski F-scoreSqueeze PlaysWeinsteinTechnical Breakout SetupsTrading TipsPremarket MoversGap Up StocksBest Dividend StocksBullish Engulfing PatternAscending Triangle PatternSwing TradingAll articles ...
  • Subscriptions
  • Account
  • Disclaimer
AffiliatePrivacy
Logo image of MLND

Millendo Therapeutics Inc (MLND) Stock News

USA - NASDAQ:MLND -

1.06
-0.06 (-5.36%)
Last: 6/25/2021, 8:00:01 PM
1.06
0 (0%)
After Hours: 6/25/2021, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News

MLND Latest News, Press Relases and Analysis

All
Press Releases
4 years ago - By: Benzinga - Mentions: IDEX LOOP VTNR PDCO ...
News Image

45 Biggest Movers From Yesterday

4 years ago - By: Benzinga - Mentions: IDRA ADMP EYES BLPH ...
News Image

12 Health Care Stocks Moving In Wednesday's Intraday Session

4 years ago - By: Halper Sadeh LLP - Mentions: FOE MX
News Image

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates FOE, MX, DISCA, MLND; Shareholders are Encouraged to Contact the Firm

4 years ago - By: Halper Sadeh LLP - Mentions: HGV NUAN
News Image

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates NUAN, HGV, HRVSF, MLND; Shareholders are Encouraged to Contact the Firm

4 years ago - By: WeissLaw LLP
News Image

SHAREHOLDER ALERT: WeissLaw LLP Investigates Millendo Therapeutics, Inc.